Clinical Trials Directory

Trials / Completed

CompletedNCT00159042

Genetic Factors Affecting the Severity of Beta Thalassemia

Identification of Novel Genetic Modifiers in Beta-thalassemia

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Deborah Rund · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Patients with genetic diseases can have widely differing severities. We are looking for genetic factors which influence the severity of beta thalassemia.

Detailed description

The understanding of the phenotypic variability of genetically homogeneous disorders represents a major challenge. In beta thalassemia, the beta globin gene is affected by a variety of mutations. The group of patients to be analyzed here is homozygous for a splice site mutation that is common in the Middle East. In contrast to this genetic homogeneity, the spectrum of the clinical phenotype ranges from mild anemia to most severe, transfusion dependent anemia. We will use a genetic linkage approach to identify modifying factors and by analyzing the efficiency of an mRNA surveillance mechanism that is referred to as nonsense-mediated decay and represents a candidate genetic modifier of beta thalassemia and other genetic disorders.

Conditions

Timeline

Start date
2004-07-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2005-09-12
Last updated
2017-08-10

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00159042. Inclusion in this directory is not an endorsement.

Genetic Factors Affecting the Severity of Beta Thalassemia (NCT00159042) · Clinical Trials Directory